| AD: | Alzheimer’s disease |
| AGE: | advanced-glycation end product |
| AGE–BSA: | AGE–bovine serum albumin |
| AGE–HSA: | AGE–human serum albumin |
| AGE-R: | AGE receptors |
| α-SMA: | α-smooth muscle actin |
| AMD: | aging-related macular degeneration |
| ARE: | antioxidant responsive element |
| CEL: | Nε-(carboxyethyl)lysine |
| CML: | Nε-(carboxymethyl)lysine |
| CVD: | cardiovascular disease |
| DM: | diabetes mellitus |
| DN: | diabetic nephropathy |
| DPP4: | dipeptidyl peptidase 4 |
| DR: | diabetic retinopathy |
| GIP-1: | glucose-dependent insulinotropic peptidase-1 |
| GLO: | glyoxalase |
| GLP-1: | glucagon-like peptide-1 |
| GO: | glyoxal |
| GOLD: | glyoxal-lysine dimer |
| HMGB1: | high-mobility group box-1 |
| HUVEC: | human umbilical vein-derived endothelial cell |
| IFN: | interferon |
| IL: | interleukin |
| ILK: | integrin-linked kinase |
| ISRE: | interferon-stimulated response element |
| Med diet: | Mediterranean diet |
| MFB: | myofibroblast |
| MGO: | methylglyoxal |
| MO: | morbid obesity |
| MOLD: | methylglyoxal-lysine dimer |
| MPO: | neutrophil myeloperoxidase |
| MR: | Maillard reaction |
| NE: | neutrophil elastase |
| Nrf2: | nuclear factor erythroid 2-related factor 2 |
| NRP-1: | neuropilin-1 |
| OX: | oxidative damage |
| OPN: | osteopontin |
| OS: | oxidative stress |
| PD: | Parkinson’s disease |
| RAA: | renin-angiotensin-aldosterone |
| RAGE: | receptor for AGE |
| RCO: | reactive carbonyl compound |
| RNI: | reactive nitrogen intermediates |
| ROS: | reactive oxygen species |
| RPEC: | retinal pigmented epithelial cell |
| SAF: | skin autofluorescence |
| Sp1: | specificity protein 1 |
| sRAGE: | soluble form RAGE |
| Th: | helper T lymphocyte |
| TNF-α: | tumor necrosis factor –α |
| Treg: | regulatory T lymphocyte |
| VEGF: | vascular endothelial cell growth factor |
| VSMC: | vascular smooth muscle cell |